nodes	percent_of_prediction	percent_of_DWPC	metapath
Metyrapone—ABCC3—hematologic cancer	0.385	1	CbGaD
Metyrapone—CYP2A6—Methoxsalen—hematologic cancer	0.0374	0.0866	CbGbCtD
Metyrapone—ABCC3—Vincristine—hematologic cancer	0.032	0.0743	CbGbCtD
Metyrapone—ABCC3—Cisplatin—hematologic cancer	0.0299	0.0693	CbGbCtD
Metyrapone—ABCC3—Etoposide—hematologic cancer	0.0293	0.0681	CbGbCtD
Metyrapone—CYP2A6—Ifosfamide—hematologic cancer	0.0273	0.0632	CbGbCtD
Metyrapone—CYP2E1—Thalidomide—hematologic cancer	0.0204	0.0474	CbGbCtD
Metyrapone—ABCC3—Doxorubicin—hematologic cancer	0.02	0.0464	CbGbCtD
Metyrapone—ABCC3—Methotrexate—hematologic cancer	0.0194	0.045	CbGbCtD
Metyrapone—CYP2A6—Prednisolone—hematologic cancer	0.0182	0.0421	CbGbCtD
Metyrapone—CYP2E1—Dacarbazine—hematologic cancer	0.0176	0.0407	CbGbCtD
Metyrapone—CYP2E1—Mitoxantrone—hematologic cancer	0.0136	0.0316	CbGbCtD
Metyrapone—CYP3A4—Bexarotene—hematologic cancer	0.0116	0.0269	CbGbCtD
Metyrapone—CYP3A4—Lomustine—hematologic cancer	0.0108	0.025	CbGbCtD
Metyrapone—CYP3A4—Busulfan—hematologic cancer	0.0108	0.025	CbGbCtD
Metyrapone—CYP2A6—Dexamethasone—hematologic cancer	0.0107	0.0248	CbGbCtD
Metyrapone—CYP3A4—Thiotepa—hematologic cancer	0.00961	0.0223	CbGbCtD
Metyrapone—CYP2E1—Etoposide—hematologic cancer	0.0086	0.0199	CbGbCtD
Metyrapone—CYP3A4—Methoxsalen—hematologic cancer	0.00747	0.0173	CbGbCtD
Metyrapone—CYP3A4—Bortezomib—hematologic cancer	0.00711	0.0165	CbGbCtD
Metyrapone—CYP2E1—Dexamethasone—hematologic cancer	0.00707	0.0164	CbGbCtD
Metyrapone—CYP3A4—Daunorubicin—hematologic cancer	0.0068	0.0158	CbGbCtD
Metyrapone—CYP3A4—Cytarabine—hematologic cancer	0.006	0.0139	CbGbCtD
Metyrapone—CYP3A4—Teniposide—hematologic cancer	0.00591	0.0137	CbGbCtD
Metyrapone—CYP3A4—Ifosfamide—hematologic cancer	0.00545	0.0126	CbGbCtD
Metyrapone—CYP3A4—Imatinib—hematologic cancer	0.00521	0.0121	CbGbCtD
Metyrapone—CYP3A4—Ruxolitinib—hematologic cancer	0.0049	0.0114	CbGbCtD
Metyrapone—CYP3A4—Nilotinib—hematologic cancer	0.00473	0.011	CbGbCtD
Metyrapone—CYP3A4—Vinorelbine—hematologic cancer	0.00469	0.0109	CbGbCtD
Metyrapone—CYP3A4—Triamcinolone—hematologic cancer	0.00429	0.00995	CbGbCtD
Metyrapone—CYP3A4—Dasatinib—hematologic cancer	0.00418	0.0097	CbGbCtD
Metyrapone—CYP3A4—Mitoxantrone—hematologic cancer	0.00413	0.00958	CbGbCtD
Metyrapone—CYP3A4—Betamethasone—hematologic cancer	0.00368	0.00854	CbGbCtD
Metyrapone—CYP3A4—Prednisolone—hematologic cancer	0.00363	0.00842	CbGbCtD
Metyrapone—CYP3A4—Prednisone—hematologic cancer	0.00343	0.00796	CbGbCtD
Metyrapone—CYP3A4—Irinotecan—hematologic cancer	0.00325	0.00754	CbGbCtD
Metyrapone—CYP11B1—hematopoietic system—hematologic cancer	0.00294	0.158	CbGeAlD
Metyrapone—CYP11B2—hematopoietic system—hematologic cancer	0.00294	0.158	CbGeAlD
Metyrapone—CYP3A4—Vinblastine—hematologic cancer	0.00289	0.00671	CbGbCtD
Metyrapone—CYP3A4—Vincristine—hematologic cancer	0.00284	0.00659	CbGbCtD
Metyrapone—CYP3A4—Etoposide—hematologic cancer	0.00261	0.00604	CbGbCtD
Metyrapone—CYP3A4—Dexamethasone—hematologic cancer	0.00214	0.00497	CbGbCtD
Metyrapone—CYP11B2—blood—hematologic cancer	0.00195	0.105	CbGeAlD
Metyrapone—CYP11B1—blood—hematologic cancer	0.00195	0.105	CbGeAlD
Metyrapone—CYP3A4—Doxorubicin—hematologic cancer	0.00178	0.00412	CbGbCtD
Metyrapone—ABCC3—hematopoietic system—hematologic cancer	0.0013	0.0698	CbGeAlD
Metyrapone—CYP11B2—lymph node—hematologic cancer	0.00117	0.0628	CbGeAlD
Metyrapone—ABCC3—blood—hematologic cancer	0.000859	0.0462	CbGeAlD
Metyrapone—CYP2A6—lung—hematologic cancer	0.000804	0.0433	CbGeAlD
Metyrapone—ABCC3—lung—hematologic cancer	0.000753	0.0405	CbGeAlD
Metyrapone—ABCC3—testis—hematologic cancer	0.000711	0.0382	CbGeAlD
Metyrapone—CYP2E1—hematopoietic system—hematologic cancer	0.000654	0.0352	CbGeAlD
Metyrapone—CYP3A4—hematopoietic system—hematologic cancer	0.000526	0.0283	CbGeAlD
Metyrapone—ABCC3—lymph node—hematologic cancer	0.000515	0.0277	CbGeAlD
Metyrapone—CYP2E1—blood—hematologic cancer	0.000433	0.0233	CbGeAlD
Metyrapone—CYP2E1—lung—hematologic cancer	0.00038	0.0204	CbGeAlD
Metyrapone—CYP2E1—testis—hematologic cancer	0.000358	0.0193	CbGeAlD
Metyrapone—CYP3A4—blood—hematologic cancer	0.000349	0.0188	CbGeAlD
Metyrapone—Hypotension—Thalidomide—hematologic cancer	0.000135	0.00101	CcSEcCtD
Metyrapone—Nervous system disorder—Alitretinoin—hematologic cancer	0.000135	0.00101	CcSEcCtD
Metyrapone—Pain—Vinorelbine—hematologic cancer	0.000134	0.000999	CcSEcCtD
Metyrapone—Skin disorder—Alitretinoin—hematologic cancer	0.000134	0.000998	CcSEcCtD
Metyrapone—Alopecia—Etoposide—hematologic cancer	0.000134	0.000997	CcSEcCtD
Metyrapone—Nervous system disorder—Ifosfamide—hematologic cancer	0.000134	0.000995	CcSEcCtD
Metyrapone—Hypertension—Gemcitabine—hematologic cancer	0.000133	0.000993	CcSEcCtD
Metyrapone—Dizziness—Nilotinib—hematologic cancer	0.000133	0.000992	CcSEcCtD
Metyrapone—Dizziness—Imatinib—hematologic cancer	0.000132	0.000987	CcSEcCtD
Metyrapone—Skin disorder—Ifosfamide—hematologic cancer	0.000132	0.000986	CcSEcCtD
Metyrapone—Nausea—Procarbazine—hematologic cancer	0.000132	0.000984	CcSEcCtD
Metyrapone—Gastrointestinal pain—Bortezomib—hematologic cancer	0.000131	0.000979	CcSEcCtD
Metyrapone—Vomiting—Chlorambucil—hematologic cancer	0.000131	0.000976	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—hematologic cancer	0.00013	0.000973	CcSEcCtD
Metyrapone—Nervous system disorder—Vincristine—hematologic cancer	0.00013	0.000971	CcSEcCtD
Metyrapone—Dizziness—Cladribine—hematologic cancer	0.00013	0.00097	CcSEcCtD
Metyrapone—Hypotension—Carmustine—hematologic cancer	0.00013	0.000969	CcSEcCtD
Metyrapone—Nausea—Bexarotene—hematologic cancer	0.000129	0.000965	CcSEcCtD
Metyrapone—Nausea—Dasatinib—hematologic cancer	0.000129	0.000965	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Thiotepa—hematologic cancer	0.000129	0.000964	CcSEcCtD
Metyrapone—Nausea—Fludarabine—hematologic cancer	0.000129	0.000962	CcSEcCtD
Metyrapone—Hypotension—Alitretinoin—hematologic cancer	0.000129	0.00096	CcSEcCtD
Metyrapone—Gastrointestinal pain—Vinorelbine—hematologic cancer	0.000128	0.000956	CcSEcCtD
Metyrapone—Pain—Thiotepa—hematologic cancer	0.000128	0.000954	CcSEcCtD
Metyrapone—Vomiting—Nilotinib—hematologic cancer	0.000128	0.000954	CcSEcCtD
Metyrapone—Vomiting—Imatinib—hematologic cancer	0.000127	0.000949	CcSEcCtD
Metyrapone—Hypotension—Ifosfamide—hematologic cancer	0.000127	0.000949	CcSEcCtD
Metyrapone—Abdominal pain—Bortezomib—hematologic cancer	0.000127	0.000946	CcSEcCtD
Metyrapone—Nervous system disorder—Irinotecan—hematologic cancer	0.000127	0.000945	CcSEcCtD
Metyrapone—Headache—Nilotinib—hematologic cancer	0.000126	0.00094	CcSEcCtD
Metyrapone—Skin disorder—Mitoxantrone—hematologic cancer	0.000126	0.000936	CcSEcCtD
Metyrapone—Headache—Imatinib—hematologic cancer	0.000125	0.000935	CcSEcCtD
Metyrapone—Vomiting—Cladribine—hematologic cancer	0.000125	0.000932	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Thalidomide—hematologic cancer	0.000125	0.000932	CcSEcCtD
Metyrapone—Dizziness—Vinblastine—hematologic cancer	0.000125	0.00093	CcSEcCtD
Metyrapone—Hypotension—Vincristine—hematologic cancer	0.000124	0.000925	CcSEcCtD
Metyrapone—Abdominal pain—Vinorelbine—hematologic cancer	0.000124	0.000924	CcSEcCtD
Metyrapone—Pain—Thalidomide—hematologic cancer	0.000124	0.000923	CcSEcCtD
Metyrapone—Nervous system disorder—Gemcitabine—hematologic cancer	0.000123	0.000921	CcSEcCtD
Metyrapone—Headache—Cladribine—hematologic cancer	0.000123	0.000919	CcSEcCtD
Metyrapone—Gastrointestinal pain—Thiotepa—hematologic cancer	0.000122	0.000913	CcSEcCtD
Metyrapone—Skin disorder—Gemcitabine—hematologic cancer	0.000122	0.000912	CcSEcCtD
Metyrapone—Nausea—Chlorambucil—hematologic cancer	0.000122	0.000912	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—hematologic cancer	0.000122	0.000907	CcSEcCtD
Metyrapone—Hypotension—Mitoxantrone—hematologic cancer	0.000121	0.000901	CcSEcCtD
Metyrapone—Hypotension—Irinotecan—hematologic cancer	0.000121	0.000901	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Carmustine—hematologic cancer	0.00012	0.000895	CcSEcCtD
Metyrapone—Vomiting—Vinblastine—hematologic cancer	0.00012	0.000894	CcSEcCtD
Metyrapone—Nausea—Nilotinib—hematologic cancer	0.00012	0.000892	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Alitretinoin—hematologic cancer	0.000119	0.000887	CcSEcCtD
Metyrapone—Pain—Carmustine—hematologic cancer	0.000119	0.000887	CcSEcCtD
Metyrapone—Nausea—Imatinib—hematologic cancer	0.000119	0.000886	CcSEcCtD
Metyrapone—Gastrointestinal pain—Thalidomide—hematologic cancer	0.000118	0.000883	CcSEcCtD
Metyrapone—Abdominal pain—Thiotepa—hematologic cancer	0.000118	0.000882	CcSEcCtD
Metyrapone—Headache—Vinblastine—hematologic cancer	0.000118	0.000881	CcSEcCtD
Metyrapone—Pain—Alitretinoin—hematologic cancer	0.000118	0.000878	CcSEcCtD
Metyrapone—Hypotension—Gemcitabine—hematologic cancer	0.000118	0.000877	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Ifosfamide—hematologic cancer	0.000118	0.000876	CcSEcCtD
Metyrapone—Nausea—Cladribine—hematologic cancer	0.000117	0.000871	CcSEcCtD
Metyrapone—Pain—Ifosfamide—hematologic cancer	0.000116	0.000868	CcSEcCtD
Metyrapone—Dizziness—Lenalidomide—hematologic cancer	0.000115	0.00086	CcSEcCtD
Metyrapone—Nervous system disorder—Cisplatin—hematologic cancer	0.000115	0.000858	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Vincristine—hematologic cancer	0.000115	0.000854	CcSEcCtD
Metyrapone—Abdominal pain—Thalidomide—hematologic cancer	0.000114	0.000853	CcSEcCtD
Metyrapone—Vomiting—Melphalan—hematologic cancer	0.000114	0.000851	CcSEcCtD
Metyrapone—Skin disorder—Cisplatin—hematologic cancer	0.000114	0.00085	CcSEcCtD
Metyrapone—Hypertension—Etoposide—hematologic cancer	0.000114	0.000848	CcSEcCtD
Metyrapone—Dizziness—Hydroxyurea—hematologic cancer	0.000114	0.000848	CcSEcCtD
Metyrapone—Gastrointestinal pain—Carmustine—hematologic cancer	0.000114	0.000848	CcSEcCtD
Metyrapone—Pain—Vincristine—hematologic cancer	0.000114	0.000846	CcSEcCtD
Metyrapone—Angiopathy—Dexamethasone—hematologic cancer	0.000113	0.000843	CcSEcCtD
Metyrapone—Angiopathy—Betamethasone—hematologic cancer	0.000113	0.000843	CcSEcCtD
Metyrapone—Gastrointestinal pain—Alitretinoin—hematologic cancer	0.000113	0.00084	CcSEcCtD
Metyrapone—Hypertension—Prednisolone—hematologic cancer	0.000112	0.000837	CcSEcCtD
Metyrapone—Nausea—Vinblastine—hematologic cancer	0.000112	0.000835	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Irinotecan—hematologic cancer	0.000112	0.000832	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—hematologic cancer	0.000111	0.000831	CcSEcCtD
Metyrapone—Gastrointestinal pain—Ifosfamide—hematologic cancer	0.000111	0.00083	CcSEcCtD
Metyrapone—Vomiting—Lenalidomide—hematologic cancer	0.000111	0.000827	CcSEcCtD
Metyrapone—Pain—Mitoxantrone—hematologic cancer	0.000111	0.000824	CcSEcCtD
Metyrapone—Pain—Irinotecan—hematologic cancer	0.000111	0.000824	CcSEcCtD
Metyrapone—Alopecia—Dexamethasone—hematologic cancer	0.00011	0.000821	CcSEcCtD
Metyrapone—Alopecia—Betamethasone—hematologic cancer	0.00011	0.000821	CcSEcCtD
Metyrapone—Abdominal pain—Carmustine—hematologic cancer	0.00011	0.00082	CcSEcCtD
Metyrapone—Hypotension—Cisplatin—hematologic cancer	0.00011	0.000818	CcSEcCtD
Metyrapone—Vomiting—Hydroxyurea—hematologic cancer	0.000109	0.000815	CcSEcCtD
Metyrapone—Headache—Lenalidomide—hematologic cancer	0.000109	0.000815	CcSEcCtD
Metyrapone—Abdominal pain—Alitretinoin—hematologic cancer	0.000109	0.000812	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Gemcitabine—hematologic cancer	0.000109	0.000811	CcSEcCtD
Metyrapone—Abdominal discomfort—Methotrexate—hematologic cancer	0.000109	0.00081	CcSEcCtD
Metyrapone—Gastrointestinal pain—Vincristine—hematologic cancer	0.000109	0.000809	CcSEcCtD
Metyrapone—Headache—Hydroxyurea—hematologic cancer	0.000108	0.000803	CcSEcCtD
Metyrapone—Pain—Gemcitabine—hematologic cancer	0.000108	0.000803	CcSEcCtD
Metyrapone—Abdominal pain—Ifosfamide—hematologic cancer	0.000108	0.000802	CcSEcCtD
Metyrapone—Pancytopenia—Methotrexate—hematologic cancer	0.000108	0.000802	CcSEcCtD
Metyrapone—Nausea—Melphalan—hematologic cancer	0.000107	0.000795	CcSEcCtD
Metyrapone—Dizziness—Bortezomib—hematologic cancer	0.000106	0.000792	CcSEcCtD
Metyrapone—Gastrointestinal pain—Irinotecan—hematologic cancer	0.000106	0.000788	CcSEcCtD
Metyrapone—Gastrointestinal pain—Mitoxantrone—hematologic cancer	0.000106	0.000788	CcSEcCtD
Metyrapone—Abdominal pain—Vincristine—hematologic cancer	0.000105	0.000782	CcSEcCtD
Metyrapone—Skin disorder—Etoposide—hematologic cancer	0.000104	0.000779	CcSEcCtD
Metyrapone—Dizziness—Vinorelbine—hematologic cancer	0.000104	0.000773	CcSEcCtD
Metyrapone—Nausea—Lenalidomide—hematologic cancer	0.000104	0.000773	CcSEcCtD
Metyrapone—Hypertension—Triamcinolone—hematologic cancer	0.000103	0.000769	CcSEcCtD
Metyrapone—Abdominal pain—Mitoxantrone—hematologic cancer	0.000102	0.000762	CcSEcCtD
Metyrapone—Abdominal pain—Irinotecan—hematologic cancer	0.000102	0.000762	CcSEcCtD
Metyrapone—Nausea—Hydroxyurea—hematologic cancer	0.000102	0.000762	CcSEcCtD
Metyrapone—Vomiting—Bortezomib—hematologic cancer	0.000102	0.000761	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Cisplatin—hematologic cancer	0.000101	0.000756	CcSEcCtD
Metyrapone—Vomiting—Bleomycin—hematologic cancer	0.000101	0.000755	CcSEcCtD
Metyrapone—Pancytopenia—Epirubicin—hematologic cancer	0.000101	0.000751	CcSEcCtD
Metyrapone—Headache—Bortezomib—hematologic cancer	0.000101	0.00075	CcSEcCtD
Metyrapone—Hypotension—Etoposide—hematologic cancer	0.0001	0.000749	CcSEcCtD
Metyrapone—Pain—Cisplatin—hematologic cancer	0.0001	0.000748	CcSEcCtD
Metyrapone—Vomiting—Vinorelbine—hematologic cancer	9.97e-05	0.000743	CcSEcCtD
Metyrapone—Dizziness—Thiotepa—hematologic cancer	9.9e-05	0.000738	CcSEcCtD
Metyrapone—Angiopathy—Prednisone—hematologic cancer	9.84e-05	0.000734	CcSEcCtD
Metyrapone—Headache—Vinorelbine—hematologic cancer	9.82e-05	0.000732	CcSEcCtD
Metyrapone—Alopecia—Prednisone—hematologic cancer	9.58e-05	0.000715	CcSEcCtD
Metyrapone—Dizziness—Thalidomide—hematologic cancer	9.57e-05	0.000714	CcSEcCtD
Metyrapone—Nausea—Bortezomib—hematologic cancer	9.53e-05	0.000711	CcSEcCtD
Metyrapone—Vomiting—Thiotepa—hematologic cancer	9.52e-05	0.00071	CcSEcCtD
Metyrapone—Nausea—Bleomycin—hematologic cancer	9.46e-05	0.000706	CcSEcCtD
Metyrapone—Headache—Thiotepa—hematologic cancer	9.38e-05	0.000699	CcSEcCtD
Metyrapone—Hypertension—Dexamethasone—hematologic cancer	9.36e-05	0.000698	CcSEcCtD
Metyrapone—Hypertension—Betamethasone—hematologic cancer	9.36e-05	0.000698	CcSEcCtD
Metyrapone—Pancytopenia—Doxorubicin—hematologic cancer	9.31e-05	0.000694	CcSEcCtD
Metyrapone—Nausea—Vinorelbine—hematologic cancer	9.31e-05	0.000694	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Etoposide—hematologic cancer	9.28e-05	0.000692	CcSEcCtD
Metyrapone—Vomiting—Thalidomide—hematologic cancer	9.2e-05	0.000686	CcSEcCtD
Metyrapone—Dizziness—Carmustine—hematologic cancer	9.19e-05	0.000686	CcSEcCtD
Metyrapone—Pain—Etoposide—hematologic cancer	9.19e-05	0.000686	CcSEcCtD
Metyrapone—Dizziness—Alitretinoin—hematologic cancer	9.11e-05	0.000679	CcSEcCtD
Metyrapone—Headache—Thalidomide—hematologic cancer	9.07e-05	0.000676	CcSEcCtD
Metyrapone—Pain—Prednisolone—hematologic cancer	9.07e-05	0.000676	CcSEcCtD
Metyrapone—Dizziness—Ifosfamide—hematologic cancer	9e-05	0.000671	CcSEcCtD
Metyrapone—Nausea—Thiotepa—hematologic cancer	8.89e-05	0.000663	CcSEcCtD
Metyrapone—Vomiting—Carmustine—hematologic cancer	8.84e-05	0.000659	CcSEcCtD
Metyrapone—Gastrointestinal pain—Etoposide—hematologic cancer	8.79e-05	0.000656	CcSEcCtD
Metyrapone—Dizziness—Vincristine—hematologic cancer	8.78e-05	0.000654	CcSEcCtD
Metyrapone—Vomiting—Alitretinoin—hematologic cancer	8.76e-05	0.000653	CcSEcCtD
Metyrapone—Headache—Carmustine—hematologic cancer	8.71e-05	0.00065	CcSEcCtD
Metyrapone—Nervous system disorder—Dexamethasone—hematologic cancer	8.68e-05	0.000647	CcSEcCtD
Metyrapone—Nervous system disorder—Betamethasone—hematologic cancer	8.68e-05	0.000647	CcSEcCtD
Metyrapone—Vomiting—Ifosfamide—hematologic cancer	8.66e-05	0.000645	CcSEcCtD
Metyrapone—Headache—Alitretinoin—hematologic cancer	8.63e-05	0.000643	CcSEcCtD
Metyrapone—Nausea—Thalidomide—hematologic cancer	8.6e-05	0.000641	CcSEcCtD
Metyrapone—Dizziness—Irinotecan—hematologic cancer	8.55e-05	0.000637	CcSEcCtD
Metyrapone—Abdominal pain—Etoposide—hematologic cancer	8.5e-05	0.000634	CcSEcCtD
Metyrapone—Vomiting—Vincristine—hematologic cancer	8.44e-05	0.000629	CcSEcCtD
Metyrapone—Pain—Triamcinolone—hematologic cancer	8.34e-05	0.000622	CcSEcCtD
Metyrapone—Headache—Vincristine—hematologic cancer	8.31e-05	0.00062	CcSEcCtD
Metyrapone—Hypotension—Dexamethasone—hematologic cancer	8.27e-05	0.000617	CcSEcCtD
Metyrapone—Hypotension—Betamethasone—hematologic cancer	8.27e-05	0.000617	CcSEcCtD
Metyrapone—Nausea—Carmustine—hematologic cancer	8.26e-05	0.000616	CcSEcCtD
Metyrapone—Angiopathy—Methotrexate—hematologic cancer	8.22e-05	0.000613	CcSEcCtD
Metyrapone—Vomiting—Irinotecan—hematologic cancer	8.22e-05	0.000613	CcSEcCtD
Metyrapone—Vomiting—Mitoxantrone—hematologic cancer	8.22e-05	0.000613	CcSEcCtD
Metyrapone—Nausea—Alitretinoin—hematologic cancer	8.18e-05	0.00061	CcSEcCtD
Metyrapone—Hypertension—Prednisone—hematologic cancer	8.15e-05	0.000608	CcSEcCtD
Metyrapone—Headache—Mitoxantrone—hematologic cancer	8.1e-05	0.000604	CcSEcCtD
Metyrapone—Headache—Irinotecan—hematologic cancer	8.1e-05	0.000604	CcSEcCtD
Metyrapone—Nausea—Ifosfamide—hematologic cancer	8.09e-05	0.000603	CcSEcCtD
Metyrapone—Alopecia—Methotrexate—hematologic cancer	8.01e-05	0.000597	CcSEcCtD
Metyrapone—Vomiting—Gemcitabine—hematologic cancer	8.01e-05	0.000597	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	7.98e-05	0.000595	CcSEcCtD
Metyrapone—Headache—Gemcitabine—hematologic cancer	7.89e-05	0.000588	CcSEcCtD
Metyrapone—Nausea—Vincristine—hematologic cancer	7.88e-05	0.000588	CcSEcCtD
Metyrapone—Angiopathy—Epirubicin—hematologic cancer	7.7e-05	0.000574	CcSEcCtD
Metyrapone—Nausea—Irinotecan—hematologic cancer	7.68e-05	0.000573	CcSEcCtD
Metyrapone—Nausea—Mitoxantrone—hematologic cancer	7.68e-05	0.000573	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Betamethasone—hematologic cancer	7.64e-05	0.00057	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Dexamethasone—hematologic cancer	7.64e-05	0.00057	CcSEcCtD
Metyrapone—Pain—Dexamethasone—hematologic cancer	7.57e-05	0.000564	CcSEcCtD
Metyrapone—Pain—Betamethasone—hematologic cancer	7.57e-05	0.000564	CcSEcCtD
Metyrapone—Nervous system disorder—Prednisone—hematologic cancer	7.56e-05	0.000564	CcSEcCtD
Metyrapone—Alopecia—Epirubicin—hematologic cancer	7.5e-05	0.000559	CcSEcCtD
Metyrapone—Skin disorder—Prednisone—hematologic cancer	7.49e-05	0.000558	CcSEcCtD
Metyrapone—Nausea—Gemcitabine—hematologic cancer	7.48e-05	0.000558	CcSEcCtD
Metyrapone—Vomiting—Cisplatin—hematologic cancer	7.46e-05	0.000556	CcSEcCtD
Metyrapone—Gastrointestinal pain—Betamethasone—hematologic cancer	7.24e-05	0.00054	CcSEcCtD
Metyrapone—Gastrointestinal pain—Dexamethasone—hematologic cancer	7.24e-05	0.00054	CcSEcCtD
Metyrapone—Angiopathy—Doxorubicin—hematologic cancer	7.12e-05	0.000531	CcSEcCtD
Metyrapone—Dizziness—Etoposide—hematologic cancer	7.11e-05	0.00053	CcSEcCtD
Metyrapone—Dizziness—Prednisolone—hematologic cancer	7.01e-05	0.000523	CcSEcCtD
Metyrapone—Abdominal pain—Dexamethasone—hematologic cancer	7e-05	0.000522	CcSEcCtD
Metyrapone—Abdominal pain—Betamethasone—hematologic cancer	7e-05	0.000522	CcSEcCtD
Metyrapone—Nausea—Cisplatin—hematologic cancer	6.97e-05	0.00052	CcSEcCtD
Metyrapone—Alopecia—Doxorubicin—hematologic cancer	6.94e-05	0.000517	CcSEcCtD
Metyrapone—Vomiting—Etoposide—hematologic cancer	6.84e-05	0.00051	CcSEcCtD
Metyrapone—Headache—Etoposide—hematologic cancer	6.74e-05	0.000502	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	6.67e-05	0.000498	CcSEcCtD
Metyrapone—Headache—Prednisolone—hematologic cancer	6.64e-05	0.000495	CcSEcCtD
Metyrapone—Dizziness—Triamcinolone—hematologic cancer	6.45e-05	0.000481	CcSEcCtD
Metyrapone—Nausea—Etoposide—hematologic cancer	6.39e-05	0.000476	CcSEcCtD
Metyrapone—Hypertension—Epirubicin—hematologic cancer	6.38e-05	0.000475	CcSEcCtD
Metyrapone—Nervous system disorder—Methotrexate—hematologic cancer	6.32e-05	0.000471	CcSEcCtD
Metyrapone—Gastrointestinal pain—Prednisone—hematologic cancer	6.3e-05	0.00047	CcSEcCtD
Metyrapone—Nausea—Prednisolone—hematologic cancer	6.3e-05	0.00047	CcSEcCtD
Metyrapone—Skin disorder—Methotrexate—hematologic cancer	6.26e-05	0.000466	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	6.24e-05	0.000466	CcSEcCtD
Metyrapone—Vomiting—Triamcinolone—hematologic cancer	6.2e-05	0.000462	CcSEcCtD
Metyrapone—Headache—Triamcinolone—hematologic cancer	6.11e-05	0.000456	CcSEcCtD
Metyrapone—Abdominal pain—Prednisone—hematologic cancer	6.09e-05	0.000454	CcSEcCtD
Metyrapone—Hypotension—Methotrexate—hematologic cancer	6.02e-05	0.000449	CcSEcCtD
Metyrapone—Nervous system disorder—Epirubicin—hematologic cancer	5.91e-05	0.000441	CcSEcCtD
Metyrapone—Hypertension—Doxorubicin—hematologic cancer	5.9e-05	0.00044	CcSEcCtD
Metyrapone—Skin disorder—Epirubicin—hematologic cancer	5.85e-05	0.000437	CcSEcCtD
Metyrapone—Dizziness—Betamethasone—hematologic cancer	5.85e-05	0.000436	CcSEcCtD
Metyrapone—Dizziness—Dexamethasone—hematologic cancer	5.85e-05	0.000436	CcSEcCtD
Metyrapone—Nausea—Triamcinolone—hematologic cancer	5.79e-05	0.000432	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	5.78e-05	0.000431	CcSEcCtD
Metyrapone—Hypotension—Epirubicin—hematologic cancer	5.63e-05	0.00042	CcSEcCtD
Metyrapone—Vomiting—Betamethasone—hematologic cancer	5.63e-05	0.00042	CcSEcCtD
Metyrapone—Vomiting—Dexamethasone—hematologic cancer	5.63e-05	0.00042	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Methotrexate—hematologic cancer	5.56e-05	0.000415	CcSEcCtD
Metyrapone—Headache—Betamethasone—hematologic cancer	5.54e-05	0.000413	CcSEcCtD
Metyrapone—Headache—Dexamethasone—hematologic cancer	5.54e-05	0.000413	CcSEcCtD
Metyrapone—Pain—Methotrexate—hematologic cancer	5.51e-05	0.000411	CcSEcCtD
Metyrapone—Nervous system disorder—Doxorubicin—hematologic cancer	5.47e-05	0.000408	CcSEcCtD
Metyrapone—Skin disorder—Doxorubicin—hematologic cancer	5.42e-05	0.000404	CcSEcCtD
Metyrapone—Gastrointestinal pain—Methotrexate—hematologic cancer	5.27e-05	0.000393	CcSEcCtD
Metyrapone—Nausea—Betamethasone—hematologic cancer	5.26e-05	0.000392	CcSEcCtD
Metyrapone—Nausea—Dexamethasone—hematologic cancer	5.26e-05	0.000392	CcSEcCtD
Metyrapone—Hypotension—Doxorubicin—hematologic cancer	5.21e-05	0.000389	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Epirubicin—hematologic cancer	5.2e-05	0.000388	CcSEcCtD
Metyrapone—Pain—Epirubicin—hematologic cancer	5.15e-05	0.000384	CcSEcCtD
Metyrapone—Dizziness—Prednisone—hematologic cancer	5.1e-05	0.00038	CcSEcCtD
Metyrapone—Abdominal pain—Methotrexate—hematologic cancer	5.09e-05	0.00038	CcSEcCtD
Metyrapone—Gastrointestinal pain—Epirubicin—hematologic cancer	4.93e-05	0.000367	CcSEcCtD
Metyrapone—Vomiting—Prednisone—hematologic cancer	4.9e-05	0.000365	CcSEcCtD
Metyrapone—Headache—Prednisone—hematologic cancer	4.83e-05	0.00036	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Doxorubicin—hematologic cancer	4.81e-05	0.000359	CcSEcCtD
Metyrapone—Pain—Doxorubicin—hematologic cancer	4.77e-05	0.000356	CcSEcCtD
Metyrapone—Abdominal pain—Epirubicin—hematologic cancer	4.76e-05	0.000355	CcSEcCtD
Metyrapone—Nausea—Prednisone—hematologic cancer	4.58e-05	0.000341	CcSEcCtD
Metyrapone—Gastrointestinal pain—Doxorubicin—hematologic cancer	4.56e-05	0.00034	CcSEcCtD
Metyrapone—Abdominal pain—Doxorubicin—hematologic cancer	4.41e-05	0.000329	CcSEcCtD
Metyrapone—Dizziness—Methotrexate—hematologic cancer	4.26e-05	0.000318	CcSEcCtD
Metyrapone—Vomiting—Methotrexate—hematologic cancer	4.09e-05	0.000305	CcSEcCtD
Metyrapone—Headache—Methotrexate—hematologic cancer	4.03e-05	0.000301	CcSEcCtD
Metyrapone—Dizziness—Epirubicin—hematologic cancer	3.99e-05	0.000297	CcSEcCtD
Metyrapone—Vomiting—Epirubicin—hematologic cancer	3.83e-05	0.000286	CcSEcCtD
Metyrapone—Nausea—Methotrexate—hematologic cancer	3.83e-05	0.000285	CcSEcCtD
Metyrapone—Headache—Epirubicin—hematologic cancer	3.78e-05	0.000282	CcSEcCtD
Metyrapone—Dizziness—Doxorubicin—hematologic cancer	3.69e-05	0.000275	CcSEcCtD
Metyrapone—Nausea—Epirubicin—hematologic cancer	3.58e-05	0.000267	CcSEcCtD
Metyrapone—Vomiting—Doxorubicin—hematologic cancer	3.55e-05	0.000264	CcSEcCtD
Metyrapone—Headache—Doxorubicin—hematologic cancer	3.49e-05	0.000261	CcSEcCtD
Metyrapone—Nausea—Doxorubicin—hematologic cancer	3.31e-05	0.000247	CcSEcCtD
Metyrapone—CYP2A6—Metabolism—SLC35B2—hematologic cancer	1.71e-05	0.000545	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GBA—hematologic cancer	1.71e-05	0.000545	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ASNS—hematologic cancer	1.67e-05	0.000535	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—DCK—hematologic cancer	1.67e-05	0.000535	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—B3GAT1—hematologic cancer	1.67e-05	0.000535	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.67e-05	0.000532	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—UGT1A1—hematologic cancer	1.65e-05	0.000527	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—SLC22A1—hematologic cancer	1.61e-05	0.000513	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CRABP1—hematologic cancer	1.61e-05	0.000513	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—HDC—hematologic cancer	1.59e-05	0.000507	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—CD44—hematologic cancer	1.57e-05	0.000502	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—NQO1—hematologic cancer	1.57e-05	0.000502	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ALOX5—hematologic cancer	1.57e-05	0.0005	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—MTAP—hematologic cancer	1.56e-05	0.000499	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.54e-05	0.000493	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.54e-05	0.000491	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—GSTP1—hematologic cancer	1.52e-05	0.000486	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—NUP98—hematologic cancer	1.52e-05	0.000484	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—CYCS—hematologic cancer	1.49e-05	0.000475	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—HSP90AA1—hematologic cancer	1.48e-05	0.000472	CbGpPWpGaD
Metyrapone—CYP2A6—NRF2 pathway—TGFB1—hematologic cancer	1.48e-05	0.000472	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ADCY7—hematologic cancer	1.47e-05	0.00047	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—NCOA3—hematologic cancer	1.47e-05	0.00047	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.47e-05	0.00047	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—NUP214—hematologic cancer	1.46e-05	0.000467	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CDA—hematologic cancer	1.45e-05	0.000463	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.45e-05	0.000462	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—ABCB1—hematologic cancer	1.44e-05	0.00046	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ABCG2—hematologic cancer	1.43e-05	0.000457	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—MTR—hematologic cancer	1.43e-05	0.000457	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ENO2—hematologic cancer	1.4e-05	0.000448	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—GSTM1—hematologic cancer	1.4e-05	0.000446	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—NCOR1—hematologic cancer	1.4e-05	0.000446	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PC—hematologic cancer	1.4e-05	0.000446	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—FHL2—hematologic cancer	1.39e-05	0.000444	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—AGRN—hematologic cancer	1.37e-05	0.000436	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—GSTT1—hematologic cancer	1.36e-05	0.000435	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—SLC35B2—hematologic cancer	1.35e-05	0.000431	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GBA—hematologic cancer	1.35e-05	0.000431	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.34e-05	0.000428	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—SDC1—hematologic cancer	1.33e-05	0.000425	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.33e-05	0.000425	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—GSTP1—hematologic cancer	1.31e-05	0.000419	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—IDH2—hematologic cancer	1.29e-05	0.000413	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—HMMR—hematologic cancer	1.29e-05	0.000413	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.28e-05	0.000407	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.27e-05	0.000406	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.27e-05	0.000405	CbGpPWpGaD
Metyrapone—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	1.27e-05	0.000405	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.26e-05	0.000401	CbGpPWpGaD
Metyrapone—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	1.25e-05	0.000399	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—ABCB1—hematologic cancer	1.24e-05	0.000396	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—MTHFR—hematologic cancer	1.24e-05	0.000395	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—MTAP—hematologic cancer	1.23e-05	0.000394	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ARNTL—hematologic cancer	1.22e-05	0.000389	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—NCOR1—hematologic cancer	1.21e-05	0.000385	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—GSTM1—hematologic cancer	1.21e-05	0.000385	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.2e-05	0.000383	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—ALB—hematologic cancer	1.19e-05	0.000381	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ACP5—hematologic cancer	1.18e-05	0.000378	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CA9—hematologic cancer	1.18e-05	0.000378	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—NCOR2—hematologic cancer	1.17e-05	0.000373	CbGpPWpGaD
Metyrapone—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	1.17e-05	0.000372	CbGpPWpGaD
Metyrapone—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	1.15e-05	0.000367	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CD44—hematologic cancer	1.13e-05	0.000361	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—NQO1—hematologic cancer	1.13e-05	0.000361	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—IDH1—hematologic cancer	1.11e-05	0.000355	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.11e-05	0.000354	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ABCC3—hematologic cancer	1.1e-05	0.000351	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—TXN—hematologic cancer	1.1e-05	0.000351	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GSTO1—hematologic cancer	1.1e-05	0.000351	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—FHL2—hematologic cancer	1.1e-05	0.000351	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.09e-05	0.000348	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—AGRN—hematologic cancer	1.08e-05	0.000344	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—SPHK1—hematologic cancer	1.08e-05	0.000344	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CYCS—hematologic cancer	1.07e-05	0.000342	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—MTHFR—hematologic cancer	1.07e-05	0.00034	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—HSP90AA1—hematologic cancer	1.06e-05	0.00034	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PIK3CG—hematologic cancer	1.04e-05	0.000331	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—UGT1A1—hematologic cancer	1.03e-05	0.00033	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—HMMR—hematologic cancer	1.02e-05	0.000327	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—IDH2—hematologic cancer	1.02e-05	0.000327	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—SLC22A1—hematologic cancer	1.01e-05	0.000321	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CRABP1—hematologic cancer	1.01e-05	0.000321	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ALOX5—hematologic cancer	9.81e-06	0.000313	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—FTCD—hematologic cancer	9.72e-06	0.00031	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PHYH—hematologic cancer	9.72e-06	0.00031	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GMPS—hematologic cancer	9.72e-06	0.00031	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—CREBBP—hematologic cancer	9.63e-06	0.000307	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ARNTL—hematologic cancer	9.62e-06	0.000307	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	9.58e-06	0.000306	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—NUP98—hematologic cancer	9.5e-06	0.000303	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—GSTP1—hematologic cancer	9.44e-06	0.000301	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	9.39e-06	0.0003	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CA9—hematologic cancer	9.36e-06	0.000299	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ACP5—hematologic cancer	9.36e-06	0.000299	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—NCOR2—hematologic cancer	9.24e-06	0.000295	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ADCY7—hematologic cancer	9.22e-06	0.000294	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—NCOA3—hematologic cancer	9.22e-06	0.000294	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—NUP214—hematologic cancer	9.16e-06	0.000292	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	9.14e-06	0.000292	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PIK3CD—hematologic cancer	9.13e-06	0.000291	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—ALB—hematologic cancer	9.01e-06	0.000288	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ABCG2—hematologic cancer	8.97e-06	0.000286	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—MTR—hematologic cancer	8.97e-06	0.000286	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PIK3CG—hematologic cancer	8.95e-06	0.000286	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ABCB1—hematologic cancer	8.94e-06	0.000285	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—SMPD3—hematologic cancer	8.89e-06	0.000284	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ENO2—hematologic cancer	8.8e-06	0.000281	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—IDH1—hematologic cancer	8.8e-06	0.000281	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ABCC3—hematologic cancer	8.7e-06	0.000278	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GSTO1—hematologic cancer	8.7e-06	0.000278	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—TXN—hematologic cancer	8.7e-06	0.000278	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—GSTM1—hematologic cancer	8.68e-06	0.000277	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—NCOR1—hematologic cancer	8.68e-06	0.000277	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PIK3R1—hematologic cancer	8.62e-06	0.000275	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GSTT1—hematologic cancer	8.54e-06	0.000272	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—SPHK1—hematologic cancer	8.51e-06	0.000272	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—SDC1—hematologic cancer	8.34e-06	0.000266	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—CREBBP—hematologic cancer	8.3e-06	0.000265	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—UGT1A1—hematologic cancer	8.18e-06	0.000261	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PIK3CB—hematologic cancer	7.96e-06	0.000254	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—SLC22A1—hematologic cancer	7.96e-06	0.000254	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CRABP1—hematologic cancer	7.96e-06	0.000254	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PIK3CD—hematologic cancer	7.87e-06	0.000251	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—B3GAT1—hematologic cancer	7.77e-06	0.000248	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ASNS—hematologic cancer	7.77e-06	0.000248	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—DCK—hematologic cancer	7.77e-06	0.000248	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—ALB—hematologic cancer	7.77e-06	0.000248	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ALOX5—hematologic cancer	7.75e-06	0.000247	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—MTHFR—hematologic cancer	7.67e-06	0.000245	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—NUP98—hematologic cancer	7.51e-06	0.00024	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PIK3R1—hematologic cancer	7.43e-06	0.000237	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—HDC—hematologic cancer	7.37e-06	0.000235	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ADCY7—hematologic cancer	7.29e-06	0.000233	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—NCOA3—hematologic cancer	7.29e-06	0.000233	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—NUP214—hematologic cancer	7.24e-06	0.000231	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—NQO1—hematologic cancer	7.09e-06	0.000226	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CD44—hematologic cancer	7.09e-06	0.000226	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—MTR—hematologic cancer	7.09e-06	0.000226	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ABCG2—hematologic cancer	7.09e-06	0.000226	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ENO2—hematologic cancer	6.95e-06	0.000222	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PTEN—hematologic cancer	6.88e-06	0.000219	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PIK3CB—hematologic cancer	6.86e-06	0.000219	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.76e-06	0.000216	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GSTT1—hematologic cancer	6.74e-06	0.000215	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CDA—hematologic cancer	6.74e-06	0.000215	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CYCS—hematologic cancer	6.71e-06	0.000214	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—HSP90AA1—hematologic cancer	6.67e-06	0.000213	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—SDC1—hematologic cancer	6.59e-06	0.00021	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—EP300—hematologic cancer	6.56e-06	0.000209	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PC—hematologic cancer	6.48e-06	0.000207	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PIK3CG—hematologic cancer	6.44e-06	0.000206	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GBA—hematologic cancer	6.26e-06	0.0002	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—SLC35B2—hematologic cancer	6.26e-06	0.0002	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CREBBP—hematologic cancer	5.98e-06	0.000191	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PTEN—hematologic cancer	5.93e-06	0.000189	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GSTP1—hematologic cancer	5.92e-06	0.000189	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—MTAP—hematologic cancer	5.73e-06	0.000183	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PIK3CD—hematologic cancer	5.67e-06	0.000181	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—EP300—hematologic cancer	5.65e-06	0.00018	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—NQO1—hematologic cancer	5.61e-06	0.000179	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CD44—hematologic cancer	5.61e-06	0.000179	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ABCB1—hematologic cancer	5.6e-06	0.000179	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ALB—hematologic cancer	5.59e-06	0.000179	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GSTM1—hematologic cancer	5.44e-06	0.000174	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—NCOR1—hematologic cancer	5.44e-06	0.000174	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PIK3R1—hematologic cancer	5.35e-06	0.000171	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CYCS—hematologic cancer	5.3e-06	0.000169	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—HSP90AA1—hematologic cancer	5.27e-06	0.000168	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—FHL2—hematologic cancer	5.11e-06	0.000163	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—AGRN—hematologic cancer	5.01e-06	0.00016	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PIK3CB—hematologic cancer	4.94e-06	0.000158	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PIK3CA—hematologic cancer	4.85e-06	0.000155	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—MTHFR—hematologic cancer	4.8e-06	0.000153	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—HMMR—hematologic cancer	4.75e-06	0.000152	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—IDH2—hematologic cancer	4.75e-06	0.000152	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GSTP1—hematologic cancer	4.68e-06	0.000149	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.46e-06	0.000142	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ABCB1—hematologic cancer	4.43e-06	0.000141	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CA9—hematologic cancer	4.34e-06	0.000139	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ACP5—hematologic cancer	4.34e-06	0.000139	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—NCOR1—hematologic cancer	4.3e-06	0.000137	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GSTM1—hematologic cancer	4.3e-06	0.000137	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.28e-06	0.000137	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PTEN—hematologic cancer	4.27e-06	0.000136	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PIK3CA—hematologic cancer	4.18e-06	0.000133	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—IDH1—hematologic cancer	4.08e-06	0.00013	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—EP300—hematologic cancer	4.07e-06	0.00013	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PIK3CG—hematologic cancer	4.04e-06	0.000129	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—TXN—hematologic cancer	4.04e-06	0.000129	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GSTO1—hematologic cancer	4.04e-06	0.000129	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ABCC3—hematologic cancer	4.04e-06	0.000129	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—AKT1—hematologic cancer	3.96e-06	0.000126	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.95e-06	0.000126	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—MTHFR—hematologic cancer	3.8e-06	0.000121	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.79e-06	0.000121	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CREBBP—hematologic cancer	3.74e-06	0.000119	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.69e-06	0.000118	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.69e-06	0.000118	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.6e-06	0.000115	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PIK3CD—hematologic cancer	3.55e-06	0.000113	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ALB—hematologic cancer	3.5e-06	0.000112	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—NUP98—hematologic cancer	3.48e-06	0.000111	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—AKT1—hematologic cancer	3.42e-06	0.000109	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.38e-06	0.000108	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.38e-06	0.000108	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—NUP214—hematologic cancer	3.36e-06	0.000107	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PIK3R1—hematologic cancer	3.35e-06	0.000107	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—MTR—hematologic cancer	3.29e-06	0.000105	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.29e-06	0.000105	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ENO2—hematologic cancer	3.23e-06	0.000103	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PIK3CG—hematologic cancer	3.19e-06	0.000102	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.13e-06	9.99e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PIK3CB—hematologic cancer	3.09e-06	9.87e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—SDC1—hematologic cancer	3.06e-06	9.76e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PIK3CA—hematologic cancer	3.01e-06	9.61e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CREBBP—hematologic cancer	2.96e-06	9.44e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PIK3CD—hematologic cancer	2.8e-06	8.95e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ALB—hematologic cancer	2.77e-06	8.84e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PTEN—hematologic cancer	2.67e-06	8.53e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PIK3R1—hematologic cancer	2.65e-06	8.45e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CD44—hematologic cancer	2.6e-06	8.3e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—NQO1—hematologic cancer	2.6e-06	8.3e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—EP300—hematologic cancer	2.55e-06	8.14e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CYCS—hematologic cancer	2.46e-06	7.85e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—AKT1—hematologic cancer	2.46e-06	7.85e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.45e-06	7.8e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PIK3CB—hematologic cancer	2.44e-06	7.8e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.17e-06	6.92e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PTEN—hematologic cancer	2.11e-06	6.74e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.05e-06	6.55e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—EP300—hematologic cancer	2.01e-06	6.43e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.99e-06	6.36e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.99e-06	6.36e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PIK3CA—hematologic cancer	1.89e-06	6.02e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.76e-06	5.62e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—AKT1—hematologic cancer	1.54e-06	4.92e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PIK3CA—hematologic cancer	1.49e-06	4.76e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.48e-06	4.72e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.37e-06	4.38e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.3e-06	4.15e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ALB—hematologic cancer	1.28e-06	4.1e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.23e-06	3.92e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—AKT1—hematologic cancer	1.22e-06	3.89e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.13e-06	3.62e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PTEN—hematologic cancer	9.8e-07	3.13e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—EP300—hematologic cancer	9.35e-07	2.98e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PIK3CA—hematologic cancer	6.91e-07	2.21e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—AKT1—hematologic cancer	5.65e-07	1.8e-05	CbGpPWpGaD
